Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B

Delayed Quote. Delayed BATS Europe - 07/29 11:29:59 am
400.05 DKK   +1.79%
07/27 NOVO NORDISK A/ : A/S : - Share repurchase programme
07/24 NOVO NORDISK A/ : Appointment Notice - Novo Nordisk Canada Inc.
07/20 NOVO NORDISK A/ : A/S : - Share repurchase programme
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
07/27 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/27 NOVO NORDISK A/S : Share repurchase programme
07/25 NOVO NORDISK A/S : appoints new head of IR
07/24 NOVO NORDISK A/S : Appointment Notice - Novo Nordisk Canada Inc.
07/24 NOVO NORDISK A/S : and Legend Dominique Wilkins Kick Off My Diabetes Dream Team ..
07/24 NOVO NORDISK A/S : Appointment Notice - Novo Nordisk Canada
07/22 NOVO NORDISK A/S : Receives FDA Approval for FlexPro® PenMate® for People with G..
07/22 NOVO NORDISK A/S : Findings from Novo Nordisk Provides New Data on Alzheimer Dis..
07/22 NOVO NORDISK A/S : Data from Novo Nordisk Provide New Insights into Clinical Tri..
07/22 NOVO NORDISK A/S : Researchers from Novo Nordisk Detail Findings in Obesity (Sav..
07/21 NOVO NORDISK A/S : Share repurchase programme
07/20 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/16 NOVO NORDISK A/S : IndyCar racer Charlie Kimball making visit at Hy-Vee
07/15 NOVO NORDISK A/S : Study Findings on Immunoglobulins Are Outlined in Reports fro..
07/13 NOVO NORDISK A/S : Share repurchase programme
07/13 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/13 NOVO NORDISK A/S : Share repurchase programme
07/11 NOVO NORDISK A/S : successfully completes first phase 3a trial with semaglutide ..
07/10 NOVO NORDISK A/S : successfully completes first phase 3a trial with semaglutide ..
07/08 NOVO NORDISK A/S : Findings on Hematology Research Reported by Researchers at No..
07/08 NOVO NORDISK A/S : Study Findings on Proteomics Are Outlined in Reports from Nov..
07/08 NOVO NORDISK A/S : New Findings on Inflammatory Bowel Diseases Described by Inve..
07/08 NOVO NORDISK A/S : Reports Summarize Proinsulin Study Results from Novo Nordisk ..
07/07 NOVO NORDISK A/S : Share repurchase programme
07/07 Zosano Pharma Announces Discontinuation of Novo Nordisk GLP-1 Patch Collabora..
07/06 NOVO NORDISK A/S : Diabetes Screening in Kenya – ‘It Takes Only 5 Se..
07/06 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/02 NOVO NORDISK A/S : Will new diet drug prove safe, effective - and affordable?
07/02 NOVO NORDISK A/S : Share repurchase programme
07/02 NOVO NORDISK A/S : Between Health and Faith - Managing Diabetes During Ramadan
07/02 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
07/01 NOVO NORDISK A/S : Patent Issued for Therapeutic Factor VIII Antibodies
07/01 NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Obesity Reported (I..
07/01 NOVO NORDISK A/S : New Diabetes Study Findings Recently Were Reported by Researc..
07/01 NOVO NORDISK A/S : Findings from Novo Nordisk Provide New Insights into Transcri..
07/01DJNovo Nordisk to Stop Selling Key Insulin Drug in Germany
07/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
07/01 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/30 NOVO NORDISK A/S : Closing the Gap Between Production and Patient
06/26 NOVO NORDISK A/S : Levemir® receives positive CHMP opinion for extended use in c..
06/26 Cinven agrees to buy majority stake in German Synlab
06/24 NOVO NORDISK A/S : Findings from Novo Nordisk Yields New Data on Proinsulin (Inv..
06/24 NOVO NORDISK A/S : Patent Issued for Method for Making Mature Insulin Polypeptid..
06/24 NOVO NORDISK A/S : Collaboration As The Means To The End
06/24 NOVO NORDISK A/S : In a phase 3 trial, NovoEight® provided long-term efficacy an..
06/24 NOVO NORDISK A/S : Fase 3-studie med NovoEight® viser langvarig effekt og sikker..
06/24 NOVO NORDISK A/S : New Novo Nordisk Data Demonstrate Caregiver Burden and Preval..
06/23 NOVO NORDISK A/S : Share repurchase programme
06/22 NOVO NORDISK A/S : Aktietilbagekøbsprogram
06/22 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/17 NOVO NORDISK A/S : Findings in the Area of Obesity and Diabetes Reported from No..
06/17 NOVO NORDISK A/S : The Results are in… Team Novo Nordisk caps off another..
06/15 NOVO NORDISK A/S : Share repurchase programme
06/15 NOVO NORDISK A/S : Three Years in a Row: Novo Nordisk In Turkey Recognised for E..
06/15 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/09 NOVO NORDISK A/S : #15 on Top Green Companies in the World
06/08 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/08 NOVO NORDISK A/S : New study with Victoza® (liraglutide) showed improvements in ..
06/08 NOVO NORDISK A/S : Nyt fase 3b-studie med Xultophy® (IDegLira) viser statistisk ..
06/08 NOVO NORDISK A/S : Share repurchase programme
06/07 NOVO NORDISK A/S : New Xultophy® (IDegLira) Phase 3b Study Showed Statistically ..
06/03 NOVO NORDISK A/S : in the US – Teaming Up to Change Diabetes
06/03 NOVO NORDISK A/S : $532.61 Million Federal Contract Awarded to Novo Nordisk
06/01 NOVO NORDISK A/S : CONTRACT AWARD - 65-- Human Insulin Novo Nordisk, Inc. July 1..
06/01 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/01 NOVO NORDISK A/S : Share repurchase programme
05/27 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Ulcerativ..
05/27 NOVO NORDISK A/S : Patent Issued for Insulins with an Acyl Moiety Comprising Rep..
05/27 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Findings in Proinsulin (..
05/27 EXCLUSIVE : Greece owes drugmakers $1.2 billion - and counting
05/22 NOVO NORDISK A/S : Treatment with Saxenda® for three years reduced the risk of d..
05/22 NOVO NORDISK A/S : Behandling med Saxenda® i tre år nedsætter risikoen for at ud..
05/22DJNOVO NORDISK A/S : Hails Success in Diabetes Drug Trial
05/21 NOVO NORDISK A/S : Share repurchase programme
05/20DJNOVO NORDISK A/S : Signs Autoimmune Disease License Agreement with Janssen
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials